Place · Level 3
Rome IV 全球约 4% · 分型 IBS-D/C/M · 低 FODMAP 三阶段 · 肠脑轴 · SIBO 测试陷阱 · 红旗清单
synergy · 1
Ford 2018 AGA meta: strain-specific — Lacto + Bifido blends help IBS-M/IBS-D global symptoms at B-tier evidence; 'broad-spectrum' is mostly a category error.
regulates · 4
Gut-brain axis is bidirectional: 40-60% of IBS patients have depression/anxiety; anxiety/depression independently provokes IBS symptoms. Shared serotonin (95% gut + 5% brain). Treating one often treats both — but SSRI/TCA dosing in IBS differs from psychiatric use.
IBS is not only a bowel problem — it sits on the gut-brain axis, where the vagus runs both ways and about 80% of its fibres are afferent (gut to brain). That is a fibre count, not a measure of signal traffic — the two are routinely conflated. Looking for a lesion in the bowel alone usually finds nothing and moves nothing.
Low-FODMAP is a structured diagnostic diet: short, dietitian-guided, with systematic reintroduction. Held strictly long term it starves the microbiome instead.
A path that gets cited a lot but whose evidence is still early: particles may lower tight-junction proteins (claudin, occludin), loosening the gut barrier while shifting microbial composition. The link to IBS is currently association, not causation.
contrast · 2
Foodborne illness is acute; recurring long-term diarrhoea or abdominal pain is a different problem, and treating chronic gut symptoms as one more bad meal misses the work-up that is actually needed.
Berberine with neem and oregano oil is sold as a personalised protocol in SIBO clinics, with no RCT behind it and no safety case either. The route is gastroenterology, Rome criteria and red-flag screening.